New Header Reminds Us That Ed Is Around. . .

Not primarily about Merck, but my long time buddie Ed Silverman has a nice FDA quality of evidence piece up -- in Forbes, overnight.

Do go read it all. Do it now, if you like Ed's contribution to balance in the journalism we read about life sciences here in the US.

And be assured -- Ed is irrepressible -- he will fully return under his own nameplate, or another's, soon.

Until then, stay warm; and be kind to one another.